New Product Planning: Am I Doing It Right?

Planning a new product launch can be challenging. From assessing market needs to aligning cross-functional teams, companies must follow proven strategies to ensure a smooth, successful launch that meets commercial and compliance expectations.

Cell and Gene Therapy in an Evolving Capital Market: Value Drivers to Enable and Elevate a Successful Raise

The shift in the cell and gene therapy capital market may not be shocking to those who have been watching since the post-COVID zeitgeist, when market entry of several clinical successes finally came after decades of innovation and development in the field. Slow clinical progress of many cell and gene therapy programs, coupled with a […]

Biosimilars Commercialization: Four Lessons Learned from Adalimumab

As manufacturers seek to capitalize on blockbuster biologic LOEs in the coming years, the adalimumab market has proven that a successful biosimilar launch is not guaranteed.  Biosimilars began entering the market about 18 months ago. Despite early access being achieved by leading competitors, Humira’s position in the market and likely portfolio-level rebating were able to […]